In this study, we also found that DLBCL patients with low serum albumin tended to present with aggressive clinical behavior including elevated LDH, B symptoms, advanced Ann Arbor stage and subsequent unfavorable outcome, which was consistent with previous studies19. This evidence concerns the gene ALB and diffuse large B-cell lymphoma.